not only newborn babies. Indeed, in the countries that have undertaken strategic planning, examination of newborn health can serve as a catalyst to bring maternal and child health groups together, as well as more vertical programmes such as HIV/AIDS and malaria linking maternal, neonatal, and child care, with benefits for mothers and children as well as babies. The biggest challenge is making plans operational for example India needs to train around 300,000 new community health workers to implement their action plan.
While 99% of newborn deaths are in the developing world, less than 1% of the information published on neonatal care relates to low resource settings. A number of important studies have been published or started in the last year, but more applied research is needed especially on how to reach the poor. An Article published today by The Lancet also authored by Dr. Joy Lawn provides new information on stillbirths.
The series authors state: "This goal will need ongoing investment from countries and donors and should be seen for what it is: an investment in the health of the next generation. However, money is not all that is needed. Currently, too few people are involved and too little research is underway, in view of the size of the problem. We need more champions and researchers committed to asking and answering questions that can save many lives".
Page: 1 2 Related medicine news :1
Contact: Joe Santangelo
. Rotavirus vaccine papers win the Lancets Paper of the Year 20062
. Lancets coverage of the World Health Organization Director-General election3
. The Lancet calls for transparency in the selection of a new executive director for the global fund4
. The Lancet calls on research community to address neglected disease that causes heart failure5
. AIDS debate launches Lancet podcast6
. The Lancet goes red to support fight against AIDS7
. Scientists describe face transplant technique in the Lancet8
. Lancet and Mexican government to hold meeting on health-system reform9
. Launch of the Lancet Asia Medical Forum10
. Representation from 41 countries confirmed for the Lancet Asia Medical Forum on Pandemic Influenza11
. The Lancet calls for independent scrutiny of the TGN1412 trial